Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE DES HAUTS DE FRANCE : revenue, balance sheet and financial ratios

PHARMACIE DES HAUTS DE FRANCE is a French company founded 10 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in ESCAUDAIN (59124), this company of category PME shows in 2024 a net income positive of 238 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE DES HAUTS DE FRANCE (SIREN 812558260)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue N/C N/C N/C N/C N/C N/C N/C N/C N/C
Net income 237 861 € 226 895 € 303 112 € 313 541 € 294 215 € 316 806 € 323 060 € 330 549 € 135 872 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2024, PHARMACIE DES HAUTS DE FRANCE generates positive net income of 238 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 136 k€ -> 238 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

237 861 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 34%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 65%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

33.869%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

65.328%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

49.8%

Solvency indicators evolution
PHARMACIE DES HAUTS DE FRANCE

Sector positioning

Debt ratio
33.87 2024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Good -10 pts over 3 years

In 2024, the debt ratio of PHARMACIE DES HAUTS DE FR... (33.87) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
65.33% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good +9 pts over 3 years

In 2024, the financial autonomy of PHARMACIE DES HAUTS DE FR... (65.3%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 305.94. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

305.937

Liquidity indicators evolution
PHARMACIE DES HAUTS DE FRANCE

Sector positioning

Liquidity ratio
305.94 2024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Excellent

In 2024, the liquidity ratio of PHARMACIE DES HAUTS DE FR... (305.94) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Positioning of PHARMACIE DES HAUTS DE FRANCE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of PHARMACIE DES HAUTS DE FRANCE is estimated at 3 320 715 € (range 2 312 493€ - 4 967 980€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
2312k€ 3320k€ 4967k€
3 320 715 € Range: 2 312 493€ - 4 967 980€
NAF 5 année 2024

Valuation method used

Net Income Multiple
237 861 € × 14.0x = 3 320 715 €
Range: 2 312 494€ - 4 967 980€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE DES HAUTS DE FRANCE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE DES HAUTS DE FRANCE

What is the revenue of PHARMACIE DES HAUTS DE FRANCE ?

The revenue of PHARMACIE DES HAUTS DE FRANCE is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMACIE DES HAUTS DE FRANCE profitable?

Yes, PHARMACIE DES HAUTS DE FRANCE generated a net profit of 238 k€ in 2024.

Where is the headquarters of PHARMACIE DES HAUTS DE FRANCE ?

The headquarters of PHARMACIE DES HAUTS DE FRANCE is located in ESCAUDAIN (59124), in the department Nord.

Where to find the tax return of PHARMACIE DES HAUTS DE FRANCE ?

The tax return of PHARMACIE DES HAUTS DE FRANCE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE DES HAUTS DE FRANCE operate?

PHARMACIE DES HAUTS DE FRANCE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.